Millennium Pharmaceuticals Inc. Resources | BNET
On The Insider: Meet the House Bunnies

BNET Industries

Millennium Pharmaceuticals Inc. (MLNM) is in the Pharma Industry

Revenue
Dec 31 2007
$527.5M
Profit
Dec 31 2007
$14.9M
Market Cap
May 08 2008
$8.1B

Latest News and Analysis

  • Incorporated: 1993
  • CEO: Dr. Deborah Dunsire M.D.

Millennium Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing medicines to improve the lives of patients with cancer, inflammatory bowel diseases and other inflammatory diseases. Co.'s VELCADE® (bortezomib) product for Injection, is marketed for the treatment of patients with multiple myeloma who have received at least one prior therapy and for the treatment of Mantle Cell Lymphoma, or MCL, patients who have received at least one prior therapy. Co. distributes VELCADE in the U.S. through a sole-source open access distribution model where Co. sells directly to an independent third party who in turn distributes to the wholesaler base.

Key Competitors

advertisement
Millennium Pharmaceuticals Inc. Company Info

Board of Directors

Mr. Kenneth E. Weg

Chairman

Dr. Jeffrey M. Leiden M.D., Ph

Mr. A. Grant Heidrich III

Vice-Chairman

Dr. Anthony H. Wild Ph.D.

Mr. Mark J. Levin

Dr. Charles J. Homcy M.D.

Dr. Raju S. Kucherlapati Ph.D.

Mr. Norman C. Selby

Dr. Deborah Dunsire M.D.

Mr. Robert F. Friel

Contact Information

40 Landsdowne Street

Cambridge, MA

http://www.mlnm.com

617 679-7000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement